Dr. Frank Yan joined 3E Bioventures Capital as Operating Partner in 2018 and is also the General Manager of N.B. Quadriga, a joint-venture biotechnology company, which is discovering and developing innovative drugs for oncology.
Dr. Yan has 15+ years of experience in the pharma industry (Novartis, Roche, and GSK), covering key stages of the drug discovery process, with broad experience in various disease areas. Dr. Yan has vast project leadership experience for both biologics and small molecule projects, as well as deep and extensive experience in external innovation sourcing, in/out-licensing opportunity evaluation, transaction, and alliance management with over 30 deals signed or progressed at various stages.
Dr. Yan received his Ph.D. in Structural Chemistry from New York University.